Use of natural interferon-beta in the treatment of acute hepatitis C

Phase 2A Learnings Incorporated into RewinD-LB, a Phase 2B Clinical Trial of Neflamapimod in Dementia with Lewy Bodies.

The journal of prevention of Alzheimer's disease·2024

Impaired bioavailability of interferon beta-1a when administered intramuscularly by needle-free injection.

Drug delivery·2009

Comparing the ability of various compositive outcomes to discriminate treatment effects in MS clinical trials. The Multiple Sclerosis Collaborative Research Group (MSCRG).

Multiple sclerosis (Houndmills, Basingstoke, England)·1999

Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group.

Annals of neurology·1998

Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).

Neurology·1997

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

Annals of neurology·1996

Saroglitazar improves hepatic steatosis and liver enzymes in women with polycystic ovary syndrome and MASLD: A multicenter, double-blind, placebo-controlled study.

Hepatology (Baltimore, Md.)·2026

Upholding telomeres prevents hepatic stellate cell transdifferentiation and liver fibrogenesis.

Hepatology (Baltimore, Md.)·2026

Autoimmune hepatitis and primary biliary cholangitis are among a subset of autoimmune diseases defined by profound co-prevalence and genetic risk association with the IL12 pathway.

Hepatology (Baltimore, Md.)·2026

Adjuvant pegylated interferon-alpha after nucleos(t)ide analog withdrawal drives a temporally coordinated expansion of regulatory B cells and contraction of HBV-specific T cells.

Hepatology (Baltimore, Md.)·2026

An international multicenter analysis of the outcome of pediatric first variceal hemorrhage.

Hepatology (Baltimore, Md.)·2026

AASLD EXPO: Liver biopsy.

Hepatology (Baltimore, Md.)·2026

Passive acquisition of hepatitis B virus antibodies after allogeneic hematopoietic cell transplantation.

Transfusion·2026

Intramuscular self-amplifying RNA and adenoviral RSV vaccines program distinct systemic and respiratory mucosal immune architectures.

EMBO molecular medicine·2026

Structure of Blm10:13S proteasome intermediate reveals parallel assembly pathways for the proteasome core particle.

Nature communications·2026

Epithelial NF-κB shapes protective Treg cell responses to restrain intestinal inflammation.

Nature communications·2026

Type I IFN promotes ILC2-to-ILC1 plasticity in pre-clinical radiation-induced lung injury.

Nature communications·2026

NU-1025 Modulates Immunogenic Cell Death in Bladder Cancer: A Multi-omics Insight.

SLAS technology·2026

Related Experiment Videos

Use of natural interferon-beta in the treatment of acute hepatitis C

Related Concept Videos

Phase 2A Learnings Incorporated into RewinD-LB, a Phase 2B Clinical Trial of Neflamapimod in Dementia with Lewy Bodies.

Impaired bioavailability of interferon beta-1a when administered intramuscularly by needle-free injection.

Comparing the ability of various compositive outcomes to discriminate treatment effects in MS clinical trials. The Multiple Sclerosis Collaborative Research Group (MSCRG).

Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group.

Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

Saroglitazar improves hepatic steatosis and liver enzymes in women with polycystic ovary syndrome and MASLD: A multicenter, double-blind, placebo-controlled study.

Upholding telomeres prevents hepatic stellate cell transdifferentiation and liver fibrogenesis.

Autoimmune hepatitis and primary biliary cholangitis are among a subset of autoimmune diseases defined by profound co-prevalence and genetic risk association with the IL12 pathway.

Adjuvant pegylated interferon-alpha after nucleos(t)ide analog withdrawal drives a temporally coordinated expansion of regulatory B cells and contraction of HBV-specific T cells.

An international multicenter analysis of the outcome of pediatric first variceal hemorrhage.

AASLD EXPO: Liver biopsy.

Passive acquisition of hepatitis B virus antibodies after allogeneic hematopoietic cell transplantation.

Intramuscular self-amplifying RNA and adenoviral RSV vaccines program distinct systemic and respiratory mucosal immune architectures.

Structure of Blm10:13S proteasome intermediate reveals parallel assembly pathways for the proteasome core particle.

Epithelial NF-κB shapes protective Treg cell responses to restrain intestinal inflammation.

Type I IFN promotes ILC2-to-ILC1 plasticity in pre-clinical radiation-induced lung injury.

NU-1025 Modulates Immunogenic Cell Death in Bladder Cancer: A Multi-omics Insight.

Related Experiment Videos

Use of natural interferon-beta in the treatment of acute hepatitis C

Related Concept Videos

Related Articles